Get the Stockscreener App
1.63
8.40%
0.1263
After Hours:
1.66
0.03
+1.84%
China Pharma Holdings Inc. stock is traded at $1.63, with a volume of 252.59K.
It is up +8.40% in the last 24 hours and down -30.87% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.5037
Open:
$1.47
24h Volume:
252.59K
Relative Volume:
2.68
Market Cap:
$4.80M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-4.8512
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
+10.88%
1M Performance:
-30.87%
6M Performance:
-34.25%
1Y Performance:
-48.65%
1-Day Range:
$1.45
$1.71
1-Week Range:
$1.3408
$1.90
52-Week Range:
$1.20
$4.10
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.63 | 4.80M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
149.99 | 66.56B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.33 | 45.76B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.45 | 45.66B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.00 | 16.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.82 | 12.79B | 2.76B | 1.11B | 898.10M | 22.77 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
Is China Pharma Holdings Inc (AMEX: CPHI) A Good Investment For New Investors Now? - Stocksregister
27.81%! LONGi Refreshes the World Record for the Efficiency of Monocrystalline Silicon Cells Again - digitalmore.co
WuXi group wrestles with uncertainty over pharma tariffs - Bamboo Works
China Pharma Holdings, Inc. Announces Launch of N95 Medical Protective Mask - marketscreener.com
CPHI stock touches 52-week high of $1.4 amid market fluctuations By Investing.com - Investing.com South Africa
CPHI stock touches 52-week high of $1.4 amid market fluctuations - Investing.com
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
Upcoming Stock Splits This Week (April 14 to April 18) – Stay Invested - The Globe and Mail
China Pharma Stock Set to Reverse Split on Tuesday, April 15th (NYSE:CPHI) - Defense World
CPHI stock touches 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa
CPHI stock touches 52-week low at $0.12 amid market challenges - Investing.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Crude Oil Down 2%; Chanson International Shares Spike Higher - Benzinga
Nasdaq Surges Over 400 Points; China Pharma Shares Plummet - Benzinga
US Stock Futures Slump Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern - Benzinga
US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern - Benzinga
Levi Strauss, Dave & Buster's Entertainment And 3 Stocks To Watch Heading Into Monday - Benzinga
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
China Pharma Announces 1-for-10 Reverse Stock Split - Nasdaq
Bayern Munich's Champions League bid suffers major blow as star man 'is set to be out for TWO MONTHS' - MSN
China Pharma announces 1-for-10 reverse stock split - MSN
China Pharma Holdings Inc Announces 1 for 10 Reverse Stock Split - MSN
China Pharma Holdings Announces Reverse Stock Split - TipRanks
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock SplitVietnam Investment Review - Vietnam Investment Review - VIR
China Pharma announces 1-for-10 reverse stock split By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
China hit brakes on TikTok deal after Trump announced wide-ranging tariffs, AP Source says - WFMZ.com
China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split - marketscreener.com
Geekplus Ranks Top 50 Globally, Cements Lead in Warehouse RoboticsVietnam Investment Review - Vietnam Investment Review - VIR
Pony.ai Europe Secures Luxembourg Robotaxi Testing PermitVietnam Investment Review - Vietnam Investment Review - VIR
Farrer Park Hospital & Alliance Healthcare Partner to Elevate Patient Care & Drive Sustainable HealthcareVietnam Investment Review - Vietnam Investment Review - VIR
Europe's Cleanest Airport features XLERATOR® Hand DryersVietnam Investment Review - Vietnam Investment Review - VIR
TAL Education to Release Q4 and FY2025 Financial Results on April 24Vietnam Investment Review - Vietnam Investment Review - VIR
2025 Top 50 Technologies: Convergence of Innovation Shaping a $1.8 Trillion SectorVietnam Investment Review - Vietnam Investment Review - VIR
ReTo Regained Compliance with Nasdaq's Minimum Bid Price RequirementVietnam Investment Review - Vietnam Investment Review - VIR
APP Group Pioneers Sustainable Packaging to Meet Singapore’s Eco-Conscious DemandVietnam Investment Review - Vietnam Investment Review - VIR
Anua Expands Global Reach with Amazon Launch in Europe, Middle East, and AustraliaVietnam Investment Review - Vietnam Investment Review - VIR
HSI Down 352 pts; HSTI Down 113 pts; BABA Down over 5%; HK & CHINA GAS, WH GROUP, SIMCERE PHARMA, CQRC BANK, CZBANK Hit New Highs; Market Turnover Rises - AASTOCKS.com
CNOOC Limited Subsidiary Completed the Transaction with INEOS EnergyVietnam Investment Review - Vietnam Investment Review - VIR
Sino Inno Lab and the Spark Promote I&T Integration in Daily LifeVietnam Investment Review - Vietnam Investment Review - VIR
LBB Specialties Teams Up with Kerry Group to Introduce Pharmaceutical Lactose to the Life Sciences MarketVietnam Investment Review - Vietnam Investment Review - VIR
Frontier AI Moneyball Reveals New Generation of TalentVietnam Investment Review - Vietnam Investment Review - VIR
Jewelers Mutual® Group Acquires Q ReportVietnam Investment Review - Vietnam Investment Review - VIR
Pre-market Movers: SBFM, PCSA, RSLS, SYRA... - RTTNews
Dunkin' offers free coffee on April Fools' Day - WFMZ.com
The 100 Most Valuable Players in the Premier League – Ranked from Lowest to Highest - MSN
China NT Pharma Reports Significant Losses for 2024 - TipRanks
China Pharma Holdings Inc. (CPHI) reports earnings - qz.com
StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World
Apacer Pioneers Fully Lead-Free DDR5 for a Greener FutureVietnam Investment Review - Vietnam Investment Review - VIR
Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates - Yahoo Finance
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.83%
1.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):